New test to help fight deadly melanoma

Source: Medical Xpress, February 2021

Researchers from QIMR Berghofer Medical Research Institute have developed a prototype test that can help identify if patients with deadly metastasised melanoma are likely to benefit from immunotherapy.

Details about the test and the study are being published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

READ THE ORIGINAL FULL ARTICLE